Search

Your search keyword '"Pagoni, Maria"' showing total 303 results

Search Constraints

Start Over You searched for: Author "Pagoni, Maria" Remove constraint Author: "Pagoni, Maria"
303 results on '"Pagoni, Maria"'

Search Results

6. SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors

8. Silencing Of The DNA Damage Repair Regulator PPP1R15A Sensitizes Acute Myeloid Leukemia Cells To Chemotherapy

9. Real-Life Multicenter Experience of Venetoclax in Combination with Hypomethylating Agents in Previously Untreated Adult Patients with Acute Myeloid Leukemia in Greece

10. Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy

11. 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy

13. miRNA-Based Technologies in Cancer Therapy

14. Effect of ABCG2, OCT1, and ABCB1 (MDR1) Gene Expression on Treatment-Free Remission in a EURO-SKI Subtrial

15. Views of Greek mainstream secondary school teachers towards full inclusion for all children with differences and their implications for future practice

16. P1606: PRIMARY AND SECONDARY IMMUNE THROMBOCYTOPENIA (ITP) IN ADULTS: REAL WORLD COMPARATIVE RETROSPECTIVE STUDY FROM THE ITP REGISTRY OF THE HELLENIC SOCIETY OF HEMATOLOGY

17. PB1765: DIFFERENTIAL GENE EXPRESSION PROFILE IN DNA DAMAGE SIGNALING PATHWAYS, IN DE NOVO ACUTE MYELOID LEUKEMIA AND LOW-RISK MDS PATIENTS

18. Bone Marrow Iron Stores Are Not Associated with Increased Risk for Invasive Fungal Infections in Patients with Newly Diagnosed Acute Leukemia or Myelodysplastic Syndrome in Transformation: Is There a Relationship?

19. Introduction

20. Blockchain-based food supply chain traceability: a case study in the dairy sector.

21. Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy

22. A retrospective study of azacitidine treatment in patients with intermediate-2 or high risk myelodysplastic syndromes in a real-world clinical setting in Greece

23. Differential Gene Expression Profile in DNA Damage Signaling Pathways, in De Novo Acute Myeloid Leukemia Patients before Induction Chemotherapy

25. Breakthrough candidaemia caused by phenotypically susceptible Candida spp. in patients with haematological malignancies does not correlate with established interpretive breakpoints

26. L'autoconfrontation dans la formation des conseillers en évolution professionnelle

27. L’activité du conseiller en évolution professionnelle, entre diagnostic et intervention l’intelligence professionnelle en situation

30. Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological Malignancies

31. Characterizing Kinetics and Avidity of SARS-CoV-2 Antibody Responses in COVID-19 Greek Patients

32. Discours pédagogique et construction de la signification des règles scolaires : questionnements autour de la notion de médiation

33. Vygotski et l’école

34. Le Conseil en évolution professionnelle (CEP) : quelles évolutions dans le travail d'accompagnement ? Quels enjeux pour la professionnalisation des conseillers ?

35. L’activité de diagnostic dans le travail du conseiller en évolution professionnelle

36. Gérard Vergnaud : un chercheur engagé, une contribution théorique d'actualité

37. Le Conseil en Evolution Professionnelle : Quelles évolutions dans le travail d’accompagnement ? Quels enjeux pour la professionnalisation des conseillers ?

40. Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: Results from the Hellenic Dendritic Cell Leukemia Study Group

41. Convalescent plasma therapy in an immunocompromised patient with multiple COVID ‐19 flares: a case report

42. Poor Neutralizing Antibody Responses in Patients with CLL, NHL and HL after Vaccination Against Sars-Cov-2; A Prospective Study in 132 Patients

43. Demographic, Clinical and Immunogenetic Profiles of a Greek Cohort of COVID-19 Patients

45. Kinetics of Nucleocapsid, Spike and Neutralizing Antibodies, and Viral Load in Patients with Severe COVID-19 Treated with Convalescent Plasma

46. Poor Neutralizing Antibody Responses in 132 Patients with CLL, NHL and HL after Vaccination against SARS-CoV-2: A Prospective Study

48. SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors

49. Poor Neutralizing Antibody Responses in 132 Patients with CLL, NHL and HL after Vaccination against SARS-CoV-2: A Prospective Study

50. Performance, Correlation and Kinetic Profile of Circulating Serum Fungal Biomarkers of Invasive Aspergillosis in High-Risk Patients with Hematologic Malignancies

Catalog

Books, media, physical & digital resources